Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Diagnostic Microbiology and Infectious Disease|September 19, 2009
Evidence for daptomycin Etest lot-related MIC elevations for Staphylococcus aureusLawrence Friedrich, Grace Thorne, Judith N Steenbergen, et al.
Antimicrobial Agents and Chemotherapy|May 4, 2016
Characteristics and Outcomes of Complicated Intra-abdominal Infections Involving Pseudomonas aeruginosa from a Randomized, Double-Blind, Phase 3 Ceftolozane-Tazobactam StudyBenjamin Miller, Myra W Popejoy, Ellie Hershberger, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2009
Inhibitory and bactericidal activities of daptomycin, vancomycin, and teicoplanin against methicillin-resistant Staphylococcus aureus isolates collected from 1985 to 2007Maria M Traczewski, Bradley D Katz, Judith N Steenbergen, et al.
The Journal of Clinical Investigation|October 17, 2003
Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatumJoshua D Nosanchuk, Judith N Steenbergen, Li Shi, et al.
The Journal of Antimicrobial Chemotherapy|February 22, 2005
Daptomycin tested against 915 bloodstream isolates of viridans group streptococci (eight species) and Streptococcus bovisJennifer M Streit, Judith N Steenbergen, Grace M Thorne, et al.
BMC Infectious Diseases|November 27, 2016
Outcomes of high-dose levofloxacin therapy remain bound to the levofloxacin minimum inhibitory concentration in complicated urinary tract infectionsEliana S Armstrong, Janelle A Mikulca, Daniel J Cloutier, et al.
The Journal of Antimicrobial Chemotherapy|June 18, 2010
Outcomes with daptomycin in the treatment of Staphylococcus aureus infections with a range of vancomycin MICsJason A Crompton, Donald S North, MinJung Yoon, et al.
Antibiotics (Basel, Switzerland)|September 27, 2016
The Novel Aminomethylcycline Omadacycline Has High Specificity for the Primary Tetracycline-Binding Site on the Bacterial RibosomeCorina G Heidrich, Sanya Mitova, Andreas Schedlbauer, et al.
The Journal of Antimicrobial Chemotherapy|March 20, 2016
Efficacy of ceftolozane/tazobactam versus levofloxacin in the treatment of complicated urinary tract infections (cUTIs) caused by levofloxacin-resistant pathogens: results from the ASPECT-cUTI trialJennifer A Huntington, George Sakoulas, Obiamiwe Umeh, et al.
Diagnostic Microbiology and Infectious Disease|February 29, 2008
In vitro activity of daptomycin against multidrug-resistant Staphylococcus aureus and S. aureus with known virulence factors, including community-acquired methicillin-resistant isolatesDiane M Anastasiou, Margie Morgan, Peter J Ruane, et al.
Pageof 4